{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:58Z","timestamp":1787003818006,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471619"],"award-info":[{"award-number":["82471619"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09929-9","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:07:32Z","timestamp":1774955252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-stranded DNA in the bone microenvironment promotes prostate cancer bone metastasis via the ITGA6-FAK pathway"],"prefix":"10.1038","volume":"9","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-sheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Lin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7129-4964","authenticated-orcid":false,"given":"Yuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1318-692X","authenticated-orcid":false,"given":"Ye","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"9929_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"9929_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"9929_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41585-018-0020-2","volume":"15","author":"RB Berish","year":"2018","unstructured":"Berish, R. B., Ali, A. N., Telmer, P. G., Ronald, J. A. & Leong, H. S. Translational models of prostate cancer bone metastasis. Nat. Rev. Urol. 15, 403\u2013421 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"9929_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","volume":"6","author":"U Swami","year":"2020","unstructured":"Swami, U., McFarland, T. R., Nussenzveig, R. & Agarwal, N. Advanced prostate cancer: treatment advances and future directions. Trends Cancer 6, 702\u2013715 (2020).","journal-title":"Trends Cancer"},{"key":"9929_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.annonc.2020.02.002","volume":"31","author":"R Ge","year":"2020","unstructured":"Ge, R. et al. Epigenetic modulations and lineage plasticity in advanced prostate cancer. Ann. Oncol. 31, 470\u2013479 (2020).","journal-title":"Ann. Oncol."},{"key":"9929_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.426","volume":"11","author":"C Lang","year":"2021","unstructured":"Lang, C. et al. m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin. Transl. Med. 11, e426 (2021).","journal-title":"Clin. Transl. Med."},{"key":"9929_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2022.01.015","volume":"530","author":"J Kang","year":"2022","unstructured":"Kang, J. et al. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer. Cancer Lett. 530, 156\u2013169 (2022).","journal-title":"Cancer Lett."},{"key":"9929_CR8","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/jbmr.3618","volume":"33","author":"J Fornetti","year":"2018","unstructured":"Fornetti, J., Welm, A. L. & Stewart, S. A. Understanding the bone in cancer metastasis. J. Bone Min. Res. 33, 2099\u20132113 (2018).","journal-title":"J. Bone Min. Res."},{"key":"9929_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13046-023-02610-7","volume":"42","author":"D Kong","year":"2023","unstructured":"Kong, D. et al. Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer. J. Exp. Clin. Cancer Res. 42, 45 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"9929_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbrc.2004.11.070","volume":"328","author":"T Yoneda","year":"2005","unstructured":"Yoneda, T. & Hiraga, T. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem. Biophys. Res. Commun. 328, 679\u2013687 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9929_CR11","doi-asserted-by":"publisher","first-page":"340ra73","DOI":"10.1126\/scitranslmed.aad4059","volume":"8","author":"TT Price","year":"2016","unstructured":"Price, T. T. et al. Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone. Sci. Transl. Med. 8, 340ra73 (2016).","journal-title":"Sci. Transl. Med."},{"key":"9929_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215\u20131228 (2015).","journal-title":"Cell"},{"key":"9929_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00198-019-04884-0","volume":"30","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q. et al. Differentially expressed proteins identified by TMT proteomics analysis in bone marrow microenvironment of osteoporotic patients. Osteoporos. Int. 30, 1089\u20131098 (2019).","journal-title":"Osteoporos. Int."},{"key":"9929_CR14","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1359\/JBMR.050802","volume":"20","author":"BT Feeley","year":"2005","unstructured":"Feeley, B. T. et al. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J. Bone Min. Res. 20, 2189\u20132199 (2005).","journal-title":"J. Bone Min. Res."},{"key":"9929_CR15","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00432-019-02896-1","volume":"145","author":"N Gupta","year":"2019","unstructured":"Gupta, N. et al. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma. J. Cancer Res. Clin. Oncol. 145, 1601\u20131611 (2019).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"9929_CR16","doi-asserted-by":"publisher","first-page":"107830","DOI":"10.1016\/j.celrep.2020.107830","volume":"31","author":"A Rostami","year":"2020","unstructured":"Rostami, A. et al. Senescence, necrosis, and apoptosis govern circulating cell-free DNA release kinetics. Cell Rep. 31, 107830 (2020).","journal-title":"Cell Rep."},{"key":"9929_CR17","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.1126\/science.aaw3616","volume":"372","author":"YMD Lo","year":"2021","unstructured":"Lo, Y. M. D., Han, D. S. C., Jiang, P. & Chiu, R. W. K. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science 372, 6538 (2021).","journal-title":"Science"},{"key":"9929_CR18","doi-asserted-by":"publisher","first-page":"104554","DOI":"10.1016\/j.isci.2022.104554","volume":"25","author":"J Cheng","year":"2022","unstructured":"Cheng, J. et al. Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA. iScience 25, 104554 (2022).","journal-title":"iScience"},{"key":"9929_CR19","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.isci.2022.105046","volume":"25","author":"LY Cheng","year":"2022","unstructured":"Cheng, L. Y., Dai, P., Wu, L. R., Patel, A. A. & Zhang, D. Y. Direct capture and sequencing reveal ultra-short single-stranded DNA in biofluids. iScience 25, 105046 (2022).","journal-title":"iScience"},{"key":"9929_CR20","doi-asserted-by":"publisher","first-page":"121436","DOI":"10.1016\/j.talanta.2020.121436","volume":"220","author":"HK Kordasht","year":"2020","unstructured":"Kordasht, H. K. & Hasanzadeh, M. Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis. Talanta 220, 121436 (2020).","journal-title":"Talanta"},{"key":"9929_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1210\/en.2004-1211","volume":"146","author":"A Schneider","year":"2005","unstructured":"Schneider, A. et al. Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology 146, 1727\u20131736 (2005).","journal-title":"Endocrinology"},{"key":"9929_CR22","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang, S. et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 53, D1670\u2013d6 (2025).","journal-title":"Nucleic Acids Res."},{"key":"9929_CR23","doi-asserted-by":"crossref","unstructured":"Nakhjavani, M. et al. A flow cytometry-based cell surface protein binding assay for assessing selectivity and specificity of an anticancer aptamer. J. Vis. Exp. 187, e64304 (2022).","DOI":"10.3791\/64304"},{"key":"9929_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26463-w","volume":"12","author":"L Kelly","year":"2021","unstructured":"Kelly, L., Maier, K. E., Yan, A. & Levy, M. A comparative analysis of cell surface targeting aptamers. Nat. Commun. 12, 6275 (2021).","journal-title":"Nat. Commun."},{"key":"9929_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/jci.insight.172345","volume":"9","author":"YJ Li","year":"2024","unstructured":"Li, Y. J. et al. YBX1 promotes type H vessel-dependent bone formation in an m5C-dependent manner. JCI Insight 9, 4 (2024).","journal-title":"JCI Insight"},{"key":"9929_CR26","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.cmet.2021.08.009","volume":"33","author":"CJ Li","year":"2021","unstructured":"Li, C. J. et al. Senescent immune cells release grancalcin to promote skeletal aging. Cell Metab. 33, 1957\u20131973.e6 (2021).","journal-title":"Cell Metab."},{"key":"9929_CR27","doi-asserted-by":"crossref","unstructured":"Xiao, Y. et al. Splicing factor YBX1 regulates bone marrow stromal cell fate during aging. EMBO J. 42, e111762 (2023).","DOI":"10.15252\/embj.2022111762"},{"key":"9929_CR28","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1172\/JCI99044","volume":"128","author":"CJ Li","year":"2018","unstructured":"Li, C. J. et al. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging. J. Clin. Investig. 128, 5251\u20135266 (2018).","journal-title":"J. Clin. Investig."},{"key":"9929_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.cmet.2022.05.009","volume":"34","author":"H Peng","year":"2022","unstructured":"Peng, H. et al. A mechanosensitive lipolytic factor in the bone marrow promotes osteogenesis and lymphopoiesis. Cell Metab. 34, 1168\u20131182.e6 (2022).","journal-title":"Cell Metab."},{"key":"9929_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38842-6","volume":"14","author":"X Feng","year":"2023","unstructured":"Feng, X. et al. Senescent immune cells accumulation promotes brown adipose tissue dysfunction during aging. Nat. Commun. 14, 3208 (2023).","journal-title":"Nat. Commun."},{"key":"9929_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/pros.10290","volume":"57","author":"A van Bokhoven","year":"2003","unstructured":"van Bokhoven, A. et al. Molecular characterization of human prostate carcinoma cell lines. Prostate 57, 205\u2013225 (2003).","journal-title":"Prostate"},{"key":"9929_CR32","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1177\/15353702231191206","volume":"248","author":"CW Liu","year":"2023","unstructured":"Liu, C. W. et al. Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes. Exp. Biol. Med. 248, 1695\u20131707 (2023).","journal-title":"Exp. Biol. Med."},{"key":"9929_CR33","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/mt.2014.51","volume":"22","author":"BC Wengerter","year":"2014","unstructured":"Wengerter, B. C. et al. Aptamer-targeted antigen delivery. Mol. Ther. 22, 1375\u20131387 (2014).","journal-title":"Mol. Ther."},{"key":"9929_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13046-020-01694-9","volume":"39","author":"S Camorani","year":"2020","unstructured":"Camorani, S. et al. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer. J. Exp. Clin. Cancer Res. 39, 180 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"9929_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12860-022-00416-7","volume":"23","author":"J Xu","year":"2022","unstructured":"Xu, J., Ma, L., Wang, D. & Yang, J. Uncarboxylated osteocalcin promotes proliferation and metastasis of MDA-MB-231 cells through TGF-\u03b2\/SMAD3 signaling pathway. BMC Mol. Cell Biol. 23, 18 (2022).","journal-title":"BMC Mol. Cell Biol."},{"key":"9929_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ejcb.2017.03.006","volume":"96","author":"F Panet","year":"2017","unstructured":"Panet, F. et al. PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression. Eur. J. Cell Biol. 96, 469\u2013475 (2017).","journal-title":"Eur. J. Cell Biol."},{"key":"9929_CR37","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1158\/0008-5472.CAN-04-3714","volume":"65","author":"ZJ Liu","year":"2005","unstructured":"Liu, Z. J., Lee, W. J. & Zhu, B. T. Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause. Cancer Res. 65, 5802\u20135811 (2005).","journal-title":"Cancer Res."},{"key":"9929_CR38","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/emboj.2009.48","volume":"28","author":"JM de Pereda","year":"2009","unstructured":"de Pereda, J. M., Lillo, M. P. & Sonnenberg, A. Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes. EMBO J. 28, 1180\u20131190 (2009).","journal-title":"EMBO J."},{"key":"9929_CR39","doi-asserted-by":"crossref","unstructured":"Koivusalo, S., Schmidt, A., Manninen, A. & Wenta, T. Regulation of kinase signaling pathways by \u03b16\u03b24-integrins and plectin in prostate cancer. Cancers 15, 149 (2022).","DOI":"10.3390\/cancers15010149"},{"key":"9929_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3892\/or.2016.4798","volume":"36","author":"Q Jiang","year":"2016","unstructured":"Jiang, Q. et al. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2\/-9 via the FAK\/Akt\/ERK and NF-\u03baB signaling pathways. Oncol. Rep. 36, 253\u2013262 (2016).","journal-title":"Oncol. Rep."},{"key":"9929_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2174\/1568009620666200101094736","volume":"20","author":"Z Deng","year":"2020","unstructured":"Deng, Z. et al. Disintegrin tablysin-15 suppresses cancer hallmarks in melanoma cells by blocking FAK\/Akt\/ERK and NF-\u03baB signaling. Curr. Cancer Drug Targets 20, 306\u2013315 (2020).","journal-title":"Curr. Cancer Drug Targets"},{"key":"9929_CR42","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1128\/MCB.15.2.954","volume":"15","author":"MB Calalb","year":"1995","unstructured":"Calalb, M. B., Polte, T. R. & Hanks, S. K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15, 954\u2013963 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"9929_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-022-01221-6","volume":"8","author":"Z Hu","year":"2023","unstructured":"Hu, Z. et al. Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal Transduct. Target. Ther. 8, 11 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"9929_CR44","doi-asserted-by":"crossref","unstructured":"Clark, P. E. & Torti, F. M. Prostate cancer and bone metastases: medical treatment. Clin. Orthop. Relat. Res. 415, S148\u2013S157 (2003).","DOI":"10.1097\/01.blo.0000093840.72468.e1"},{"key":"9929_CR45","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Cl\u00e9zardin","year":"2021","unstructured":"Cl\u00e9zardin, P. et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol. Rev. 101, 797\u2013855 (2021).","journal-title":"Physiol. Rev."},{"key":"9929_CR46","doi-asserted-by":"publisher","first-page":"e2110500119","DOI":"10.1073\/pnas.2110500119","volume":"119","author":"X Sun","year":"2022","unstructured":"Sun, X. et al. Elucidation of CKAP4-remodeled cell mechanics in driving metastasis of bladder cancer through aptamer-based target discovery. Proc. Natl. Acad. Sci. USA 119, e2110500119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9929_CR47","doi-asserted-by":"publisher","first-page":"26369","DOI":"10.1074\/jbc.274.37.26369","volume":"274","author":"PJ Bates","year":"1999","unstructured":"Bates, P. J., Kahlon, J. B., Thomas, S. D., Trent, J. O. & Miller, D. M. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J. Biol. Chem. 274, 26369\u201326377 (1999).","journal-title":"J. Biol. Chem."},{"key":"9929_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yexmp.2009.01.004","volume":"86","author":"PJ Bates","year":"2009","unstructured":"Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D. & Trent, J. O. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp. Mol. Pathol. 86, 151\u2013164 (2009).","journal-title":"Exp. Mol. Pathol."},{"key":"9929_CR49","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/mt.2014.117","volume":"22","author":"JP Dassie","year":"2014","unstructured":"Dassie, J. P. et al. Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen. Mol. Ther. 22, 1910\u20131922 (2014).","journal-title":"Mol. Ther."},{"key":"9929_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature 583, 133\u2013138 (2020).","journal-title":"Nature"},{"key":"9929_CR51","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1158\/0008-5472.CAN-15-1546","volume":"75","author":"MC Hawes","year":"2015","unstructured":"Hawes, M. C., Wen, F. & Elquza, E. Extracellular DNA: a bridge to cancer. Cancer Res. 75, 4260\u20134264 (2015).","journal-title":"Cancer Res."},{"key":"9929_CR52","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/onco.13869","volume":"26","author":"E Lin","year":"2021","unstructured":"Lin, E. et al. Identification of somatic gene signatures in circulating cell-free DNA associated with disease progression in metastatic prostate cancer by a novel machine learning platform. Oncologist 26, 751\u2013760 (2021).","journal-title":"Oncologist"},{"key":"9929_CR53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4103\/aja.aja_1_18","volume":"20","author":"T Gourdin","year":"2018","unstructured":"Gourdin, T. & Sonpavde, G. Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer. Asian J. Androl. 20, 230\u2013237 (2018).","journal-title":"Asian J. Androl."},{"key":"9929_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00412-015-0552-7","volume":"125","author":"J Ribeiro","year":"2016","unstructured":"Ribeiro, J., Abby, E., Livera, G. & Martini, E. RPA homologs and ssDNA processing during meiotic recombination. Chromosoma 125, 265\u2013276 (2016).","journal-title":"Chromosoma"},{"key":"9929_CR55","doi-asserted-by":"publisher","first-page":"1848233","DOI":"10.1080\/23723556.2020.1848233","volume":"8","author":"FC Lam","year":"2020","unstructured":"Lam, F. C., Kong, Y. W. & Yaffe, M. B. Inducing DNA damage through R-loops to kill cancer cells. Mol. Cell. Oncol. 8, 1848233 (2020).","journal-title":"Mol. Cell. Oncol."},{"key":"9929_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bone.2010.09.016","volume":"48","author":"JG Schneider","year":"2011","unstructured":"Schneider, J. G., Amend, S. R. & Weilbaecher, K. N. Integrins and bone metastasis: integrating tumor cell and stromal cell interactions. Bone 48, 54\u201365 (2011).","journal-title":"Bone"},{"key":"9929_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/138920311795659399","volume":"12","author":"YH Soung","year":"2011","unstructured":"Soung, Y. H., Gil, H. J., Clifford, J. L. & Chung, J. Role of \u03b16\u03b24 integrin in cell motility, invasion and metastasis of mammary tumors. Curr. Protein Pept. Sci. 12, 23\u201329 (2011).","journal-title":"Curr. Protein Pept. Sci."},{"key":"9929_CR58","first-page":"407","volume":"4","author":"E Tagliabue","year":"1998","unstructured":"Tagliabue, E. et al. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin. Cancer Res. 4, 407\u2013410 (1998).","journal-title":"Clin. Cancer Res."},{"key":"9929_CR59","first-page":"4803","volume":"53","author":"T Tennenbaum","year":"1993","unstructured":"Tennenbaum, T. et al. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res. 53, 4803\u20134810 (1993).","journal-title":"Cancer Res."},{"key":"9929_CR60","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1242\/jcs.00663","volume":"17","author":"AJ Russell","year":"2003","unstructured":"Russell, A. J. et al. Alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. J. Cell Sci. 17, 3543\u20133556 (2003). 116.","journal-title":"J. Cell Sci."},{"key":"9929_CR61","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0092-8674(00)80486-9","volume":"91","author":"LM Shaw","year":"1997","unstructured":"Shaw, L. M., Rabinovitz, I., Wang, H. H., Toker, A. & Mercurio, A. M. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 91, 949\u2013960 (1997).","journal-title":"Cell"},{"key":"9929_CR62","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","volume":"75","author":"X Song","year":"2021","unstructured":"Song, X. et al. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J. Hepatol. 75, 888\u2013899 (2021).","journal-title":"J. Hepatol."},{"key":"9929_CR63","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/cvr\/cvab132","volume":"118","author":"K Jeong","year":"2022","unstructured":"Jeong, K., Murphy, J. M., Ahn, E. E. & Lim, S. S. FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation. Cardiovasc. Res. 118, 1150\u20131163 (2022).","journal-title":"Cardiovasc. Res."},{"key":"9929_CR64","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tcb.2016.02.001","volume":"26","author":"J Alanko","year":"2016","unstructured":"Alanko, J. & Ivaska, J. Endosomes: emerging platforms for integrin-mediated FAK signalling. Trends Cell Biol. 26, 391\u2013398 (2016).","journal-title":"Trends Cell Biol."},{"key":"9929_CR65","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/ncb3250","volume":"17","author":"J Alanko","year":"2015","unstructured":"Alanko, J. et al. Integrin endosomal signalling suppresses anoikis. Nat. Cell Biol. 17, 1412\u20131421 (2015).","journal-title":"Nat. Cell Biol."},{"key":"9929_CR66","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7150\/ijms.7769","volume":"11","author":"S Gao","year":"2014","unstructured":"Gao, S. et al. Role of overexpression of MACC1 and\/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int. J. Med. Sci. 11, 268\u2013275 (2014).","journal-title":"Int. J. Med. Sci."},{"key":"9929_CR67","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1158\/1078-0432.CCR-22-0308","volume":"28","author":"A Wang-Gillam","year":"2022","unstructured":"Wang-Gillam, A. et al. Defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment refractory pancreatic cancer: a Phase I dose escalation and expansion study. Clin. Cancer Res. 28, 5254\u20135262 (2022).","journal-title":"Clin. Cancer Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09929-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09929-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09929-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:02:28Z","timestamp":1779753748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09929-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9929"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09929-9","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"708"}}